kenvue.com (KVUE): Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand Kenvue Inc. (KVUE)

Kenvue Inc. has established a resilient over-the-counter consumer health environment following its spin-off from J&J, leveraging strong consumer loyalty. The normalized PEG ratio on GURU.Markets demonstrates investment attractiveness, with the parameter stabilizing at 2.13. Global capacities ensure steady demand for essential goods, while experienced management successfully optimizes operational processes to drive organic growth.

KVUE - Kenvue Inc PEG Multiple over the range 02/21/2024 - 11/11/2026
Mass-produced product of kenvue.com

The stability of the FMCG sector and the leadership of Kenvue Inc. (KVUE) in consumer health create a solid foundation for long-term profit growth. By analyzing the weighted PEG ratio, an investor assesses the asset's market value relative to its expansion rate: a value below one signals fundamental undervaluation, allowing for the effective filtering of promising assets during periods of volatility and the identification of entry points.

Competing companies

HLN (Haleon PLC) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Verona Pharma Corp VRNA|Jyong Bio (MENS) - Price to Earnings Adjusted for Growth Rate|LGND: Price/Earnings to Growth Multiple|amneal.com - Company Value to Earnings Growth Ratio|PRGO: PEG Multiple|Alvotech S.A. - Growth-Adjusted Payback Ratio|LQDA (Liquidia Technologies) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Galapagos Corp GLPG|Price/Earnings to Growth Ratio ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Amphastar Pharmaceuticals, Inc. AMPH|PEG Multiple Pacira Pharmaceuticals PCRX|ARS Pharma - PEG Multiple|Price to Earnings Adjusted for Growth Rate Theravance Corp|Aquestive Therapeutics (AQST) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio SCPH|Price/Earnings to Growth Multiple TECX|Price/Earnings to Growth Ratio TNXP|Price/Earnings to Growth Multiple SXTC (China SXT Pharmaceuticals)|PEG Multiple eupraxiapharma.com (EPRX)|PEG Multiple BHST (BioHarvest Sciences)|invizyne.com (EXOZ) - Price to Earnings Adjusted for Growth Rate|ORMP: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ENTX (Entera Bio Ltd.)|HYFT: PEG Multiple|ABVC - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Cumberland Pharmaceuticals|Growth-Adjusted P/E Ratio QNTM (quantumbiopharma.com)|PEG Multiple FGEN|Price/Earnings to Growth Multiple Telomir Pharmaceuticals Inc TELO|Rani Therapeutics Holdings, Inc. - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income Synergy CHC Corp. (SNYR)|RLYB - Price/Earnings to Growth Ratio|LEXX - PEG Multiple|PULM (Pulmatrix) - Price/Earnings to Growth Multiple|PTHL (Pheton Holdings) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple APM|PEG Multiple Lyra Therapeutics Inc|PEG Multiple IBO|TNFA - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio cbdMD YCBD|PRFX (PainReform Ltd) - Market Cap to Earnings and Growth Ratio|Auris Medical - PEG Multiple|Growth-Adjusted Payback Ratio LIPO (Lipella Pharma)|OPTN: PEG Multiple|pieris.com (PIRS) - PEG Multiple|Price/Earnings to Growth Ratio Procaps|PTPI: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Qilian International Holding Group Limited (QLI)|Price/Earnings to Growth Multiple ACELYRIN Inc. SLRN|PEG Multiple TFFP (TFF Pharmaceuticals)